APA (7th ed.) Citation

X, T., YS, L., R, T., WW, T., XM, L., CY, W., & YP, W. (2023). TEAD4 predicts poor prognosis and transcriptionally targets PLAGL2 in serous ovarian cancer. Human cell, 36(4), 1535. https://doi.org/10.1007/s13577-023-00908-4

Chicago Style (17th ed.) Citation

X, Tong, Liu YS, Tong R, Tang WW, Li XM, Wang CY, and Wang YP. "TEAD4 Predicts Poor Prognosis and Transcriptionally Targets PLAGL2 in Serous Ovarian Cancer." Human Cell 36, no. 4 (2023): 1535. https://doi.org/10.1007/s13577-023-00908-4.

MLA (9th ed.) Citation

X, Tong, et al. "TEAD4 Predicts Poor Prognosis and Transcriptionally Targets PLAGL2 in Serous Ovarian Cancer." Human Cell, vol. 36, no. 4, 2023, p. 1535, https://doi.org/10.1007/s13577-023-00908-4.